Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Kimmoisa Oy
OY
Active
Y-tunnus 2836168-4
Kanneltie 13-A
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2017
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
EUR 231K
+38% vs 2023
EBITDA margin
5.0%
+45% vs 2023
Equity ratio
71.6%
Financial strength
Net profit 2024
EUR -903
-209% vs 2023
EBITDA — year on year
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
EUR 231K
+38%
EBITDA
EUR 12K
+45%
Net profit
EUR -903
-209%
Total assets
EUR 258K
-2%
Equity
EUR 185K
+0%
Employees
1
—
Company information
Legal name
Kimmoisa Oy
Y-tunnus number
2836168-4
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
26. toukokuuta 2017
Share capital
EUR 2 500
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-10-31
Financial year
January – December
Company purpose
Laboratorio- ja sairaanhoitovälineiden tukkukauppa Muu laillinen liiketoiminta
Contact
Address
Kanneltie 13-A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Vantaa
All Finland companies
Revenue
EUR millions
0M
0M
1M
1M
1M
1M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
EUR thousands
Item
2020
2021
2022
2023
2024
Revenue
647
313
233
168
231
Staff expenses
−3
−10
−33
−24
−52
EBITDA
248
38
12
8
12
Depreciation & amort.
−4
−4
−10
−6
−5
EBIT
244
34
2
2
7
Net financials
−10
−1
−1
−0
−7
Profit before tax
234
33
1
2
−1
Tax
48
7
1
1
0
Net profit
187
27
1
1
−1
Balance sheet
EUR thousands
Item
2020
2021
2022
2023
2024
Total assets
425
277
273
264
258
Equity
208
218
201
186
185
Long-term debt
34
—
22
22
22
Short-term debt
184
59
50
56
51
Total debt
217
59
72
78
73
Financial ratios
5-year trend
EBITDA margin
5.0%
This company
15.8%
Market median
-68% vs market
2020
2024
Equity ratio
71.6%
This company
38.2%
Market median
+87% vs market
2020
2024
Return on equity
-0.5%
This company
18.4%
Market median
-103% vs market
2020
2024
Net profit margin
-0.4%
This company
8.1%
Market median
-105% vs market
2020
2024
Asset turnover
0.89×
This company
1.12×
Market median
+21% vs market
2020
2024
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2023-11-01 – 2024-10-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-11-01 – 2023-10-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-11-01 – 2022-10-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-11-01 – 2021-10-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2019-11-01 – 2020-10-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
JP
Juha Petteri Ratas
Deputy Member
Deputy Member
2017
KA
Kimmo Antti Lahti
Chief Executive Officer
Chief Executive Officer
2017
Former (1)
JT
Jani Tapani Käsnänen
Audit
Audit
2021 – 2023
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Kimmoisa Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Jani Tapani Käsnänen
Audit
0 companies
Juha Petteri Ratas
Deputy Member
0 companies
Kimmo Antti Lahti
Chief Executive Officer
0 companies